Physician profile
Radhika S Breaden
NPI 1154462257
$55,291.63
in general payments reported to CMS, 2019-2025
10 companies · $24K in 2025
The $24K reported for 2025 was more than what 97% of Sleep Medicine (Internal Medicine) providers received nationally (typical 2025 total: $447).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $973 · 2020: $4,210 · 2021: $6,059 · 2022: $4,754 · 2023: $3,355 · 2024: $11K · 2025: $24K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $22K · Honoraria: $10K · Travel and Lodging: $4,578 · Food and Beverage: $2,449 · Education: $101.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $22,168.75 |
| Honoraria | $10,000.00 |
| Travel and Lodging | $4,577.59 |
| Food and Beverage | $2,448.71 |
| Education | $101.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $48,864.31 | 2019-2025 | Inspire |
| Eli Lilly and Company | $4,494.34 | 2025 | Zepbound |
| Jazz Pharmaceuticals INC. | $963.39 | 2019-2025 | |
| Avadel Cns Pharmaceuticals, LLC | $393.28 | 2024-2025 | Lumryz |
| Axsome Therapeutics, INC. | $207.79 | 2024-2025 | Sunosi |
| Harmony Biosciences LLC | $187.62 | 2020-2025 | |
| Arbor Pharmaceuticals, INC. | $64.53 | 2019-2021 | |
| Lilly USA, LLC | $58.91 | 2025 | Zepbound |
| Azurity Pharmaceuticals, INC. | $35.63 | 2024-2025 | Horizant |
| 3b Medical, INC. | $21.83 | 2025 | Luna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Radhika Breaden listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.